MK

Max Klement

Principal, Venture Investments at Novo Holdings

Greater London, England

Overview

Work Experience

NH

Novo Holdings

  • Principal, Venture Investments

    2022 - Current

B(

BGV (BioGeneration Ventures)

  • Principal

    2022 - 2022

    Board director at Complement Therapeutics. Board observer at Dualyx, Link Immunotherapeutics, and VarmX.

  • Senior Associate

    2020 - 2021

  • Associate

    2019 - 2020

EB

Eden Biologics

  • Project Manager/ Upstream Process Development Scientist

    2016 - 2017

HB

Hummingbird Bioscience

  • Project Manager

    2014 - 2016

UN

United Nations ESCAP

  • Environment and Development Division

    2015 - 2015

Education

Investments

Complement Therapeutics

Seed

Total Funding: $85M

Relevant Websites